1984
DOI: 10.1002/bms.1200110906
|View full text |Cite
|
Sign up to set email alerts
|

High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of di-N-desethylamiodarone, a new metabolite of amiodarone in the dog

Abstract: Amiodarone is an antiarrhythmic drug which has received considerable attention in recent years. It has been suggested that the unusual pharmacodynamic characteristics of this drug may be due in part to the influence of active metabolites. Using fast atom bombardment (FAB) mass spectrometry we have identified a new metabolite of amiodarone, the di-N-desethyl analog (DDEA). This metabolite was present in the blood of dogs treated with the parent drug, and showed a greater affinity for myocardium than did the par… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1987
1987
2010
2010

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Although the LD 50 for primary rat hepatocytes was slightly lower compared with the LD 50 for HepG2 cells, both of these values were considerably greater than the mean plasma amiodarone concentration of 0.53 M determined for mice treated with 150 mg/kg amiodarone for 4 days. The major metabolite of amiodarone in humans is DEA (Latini et al, 1984). Similar to the effects of amiodarone, DEA treatment caused a dose-dependent toxicity, but with a lower apparent LD 50 of 9 M in HepG2 cells and 10 M in primary rat hepatocytes.…”
Section: Resultsmentioning
confidence: 97%
“…Although the LD 50 for primary rat hepatocytes was slightly lower compared with the LD 50 for HepG2 cells, both of these values were considerably greater than the mean plasma amiodarone concentration of 0.53 M determined for mice treated with 150 mg/kg amiodarone for 4 days. The major metabolite of amiodarone in humans is DEA (Latini et al, 1984). Similar to the effects of amiodarone, DEA treatment caused a dose-dependent toxicity, but with a lower apparent LD 50 of 9 M in HepG2 cells and 10 M in primary rat hepatocytes.…”
Section: Resultsmentioning
confidence: 97%
“…However, the ions provide a high internal energy during the ionization process, often leading to fragmentation of the molecules. FAB is a powerful tool for the structural characterization of polar thermolabile compounds, such as a drug and its metabolites, [136][137][138][139] or natural compounds 140,141 and biomolecules. [24][25][26][27] Thermospray ionization (TSP) was developed as an LC/MS interface method by Vestal et al in 1983.…”
Section: ·3 Othersmentioning
confidence: 99%
“…Biotransformation in the liver is the main pathway for AM elimination with several metabolites being formed 7–9. These products include mono‐ N ‐desethylamiodarone (DEA), di‐ N ‐desethylamiodarone and deiodinated desethylamiodarone, each of which is present in the blood and/or plasma of human and animal models 7, 9, 10. Of these, DEA is especially important due to its pharmacological and toxicological activities and the presence of high circulating plasma and tissue levels in humans, which may exceed the concentrations of the parent drug itself 3, 11–14.…”
Section: Introductionmentioning
confidence: 99%